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Abstract A copper amine oxidase from Pichia pastoris is the 
only known non-mammalian lysyl oxidase ITur, S.S. and Lerch, 
K. (1988) FEBS Lett. 238, 74-76]. Recently, the cofactor in 
mammalian lysyl oxidase has been identified as a novel lysine 
tyrosylquinone moiety [Wang, S.X., Mure, M., Medzihradszky, 
K.F., Burlingame, A.L., Brown, D.E., Dooley, D.M., Smith, 
A.J., Kagan, H.M. and Klinman, J.P. (1996) Science 273, 1078- 
1084]. In order to identify the cofactor in P. pastoris lysyl 
oxidase, we have isolated the phenylhydrazone-derivative of the 
active-site peptide. This peptide has the active-site sequence 
conserved among topa quinone containing amine oxidases. The 
resonance Raman spectra of the phenylhydrazone derivatives of 
the enzyme, active-site peptide, and a topa qulnone model 
compound are essentially identical. Collectively, these results 
establish that P. pastoris lysyl oxidase is a topa qulnone enzyme. 
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1. Introduction 
The organic cofactor in bovine serum amine oxidase was 
identified as 2,4,5-trihydroxyphenylalanine (topa) in 1990 [1] 
and was subsequently shown to be ubiquitous in copper amine 
oxidases from bacteria to humans [2-4]. In the resting state of 
the enzyme, the cofactor is in its oxidized form as topa qui- 
none (TPQ, Fig. 1A). Several aspects of its role in the oxida- 
tive deamination reaction (Eq. 1) catalyzed by amine oxidases 
have been elucidated [2-4]. 
RCH2NH2 + 02 + H20 --* RCHO + NH3 + H202 (1) 
TPQ is produced by post-translational modification of a tyr- 
osine residue in the fully conserved active-site consensus e- 
quence, Asn-Tyr-Asp/Glu [5]. The available vidence indicates 
that the post-translational modification proceeds via a novel 
self-processing mechanism in both eukaryotic and prokaryotic 
organisms [6--8]. 
One member of the copper amine oxidase family, lysyl oxi- 
dase, catalyzes the oxidation of collagen and elastin lysyl res- 
idues during the biogenesis of connective tissue [9]. The co- 
factor in lysyl oxidase has been the subject of considerable 
speculation because the protein has much different properties 
than the known TPQ-containing enzymes (e.g. subunit molec- 
ular mass of 75-85 kDa compared to 32 kDa for lysyl oxi- 
dase). Moreover, mammalian lysyl oxidase does not contain 
*Corresponding author. Fax: (1) (406) 994-5407 or J.P. Klinman, 
Fax: (1) (510) 642-8369. 
the active-site consensus equence for TPQ [10]. The lysyl 
oxidase cofactor has now been identified as a modified tyro- 
sine covalently cross-linked to the e-amino group of a lysyl 
residue and has been designated lysine tyrosylquinone (LTQ, 
Fig. 1B) [11]. 
A copper amine oxidase with a subunit molecular mass of 
approx. 116 kDa, which is relatively large for an amine oxi- 
dase, was isolated from Pichia pastoris by Green et al. [12] 
and originally identified as a benzylamine oxidase. Subse- 
quently, Tur and Lerch reclassified the enzyme as a lysyl oxi- 
dase based on the preferential oxidation of lysine, lysine deriv- 
atives, and lysyl residues in synthetic peptides. In addition, 
fibriUar collagen was found to be a substrate for the P. pas- 
toris enzyme [13]. The P. pastoris amine oxidase displayed a 
substrate specificity that was surprisingly similar to that of 
mammalian lysyl oxidase [14]. 
These observations raise several important questions about 
the relationship among amine oxidases and specifically 
whether lysyl oxidase activity is associated with the presence 
of LTQ as a cofactor. We have undertaken identification of 
the P. pastoris lysyl oxidase cofactor and have now shown 
that the cofactor is TPQ rather than LTQ which is present 
in mammalian lysyl oxidase. 
2. Materials and methods 
2.1. Protein purification 
P. pastor& was obtained from Invitrogen or the ATCC (no. 28,485). 
Growth in minimal media with butylamine as the sole nitrogen source 
was carried out essentially as described [12]. Cells were lysed and 
collected according to Cai and Klinman [6] or by vortexing with glass 
beads. Purification of the protein for peptide isolation was carried out 
as described [12]. Protein that was sufficiently pure for resonance Ra- 
man was obtained via the following procedure. After an initial cen- 
trifugation to sediment large debris, the supernatant was centrifuged 
at 81 000 ×g prior to chromatography. The centrifuged cell extract 
was treated with DEAE fast-flow media equilibrated in 20 mM 
KPO4 buffer, pH 7.0. P. pastoris lysyl oxidase was quantitatively 
absorbed under these conditions. The DEAE was then poured into 
a column and the enzyme was eluted with 500 mM KPO4 buffer (pH 
7.0) and concentrated. Gel-filtration chromatography was then carried 
out using a 42x 1.0 cm column (33 ml gel volume) of Superose-12 at 
flow rate of 0.06 ml/min on a Pharmacia FLPC system. These steps 
provided an approx. 200-fold purification of the P. pastoris lysyl oxi- 
dase. Enzyme activity was measured with benzylamine as described 
[15]. Protein concentrations were estimated using the micro-Bradford 
assay with bovine serum albumin as a standard. Protein purity was 
assessed by SDS-PAGE. 
2.2. Phenylhydrazine labeling 
Two procedures were used. For monitoring the reaction optically, 
15 gM purified amine oxidase was titrated with 2 gM aliquots of 
recrystallized phenylhydrazine hydrochloride. The increase in chromo- 
phore absorbance was followed at 448 nm after each addition until no 
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Fig. 1. Quinone cofactor structures. (A) 2,4,5-Trihydroxyphenylala- 
nine quinone (TPQ); (B) lysine tyrosylquinone (LTQ). 
further change was observed. Excess phenylhydrazine was removed 
using a Bio-Rad DG-10 desalting column pre-equilibrated with 100 
mM NHaHCO3 (pH 8.0). Resonance Raman samples of the intact 
enzyme were prepared by incubation with a 10-fold excess of hydra- 
zine reagent over protein concentration for 8 10 h at ambient em- 
perature. Excess reagent was removed via exhaustive dialysis against 
20 mM KPO4 buffer (pH 7.0) using a flow, micro-dialysis unit. This 
procedure worked well for both phenylhydrazine and p-nitrophenyl- 
hydrazine. 
2.3. Peptide isolation and characterization 
Labeling with [14C]phenylhydrazine hydrochloride (universally la- 
beled, 5550 dpm/nmol, California Bionuclear Corp.) was performed 
as previously described [6]. Excess phenylhydrazine was removed with 
a desalting column as described. The sample was lyophilized and 
redissolved in 6 M guanidine hydrochloride and 50 mM KPO4 buffer, 
pH 7.0. Reduction and carboxymethylation were carried out as pre- 
viously described [16]. Reagents were removed using a desalting col- 
umn as described. 
The enzyme was again lyophilized and redissolved in 100 mM 
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Fig. 2. P. pastoris lysyl oxidase phenylhydrazine titration. 
NH4HCO3 containing 2 M urea and shaken at 37°C. Proteolytic 
digestion was initiated by the addition of 2% (w/w) thermolysin (Sig- 
ma) and stabilized with 2 mM CaC12 [17]. After 8 h, the reaction was 
terminated by freezing at -70°C. Labeled peptide was isolated using a 
Vydac reverse-phase C18 column pre-equilibrated with solvent A 
(0.1% trifluoroacetic acid (TFA), 5% CH3CN, H20) and eluted with 
a linear gradient from 30-50% solvent B (0.1% TFA, 80% CH3CN, 
H20) over 40 min. The eluent was monitored at 214 and 440 nm. 
Yield for the digestion was 11.1% based on incorporation of radio- 
activity in the peptide peak relative to that in the initial digest. 
The peptide recovered from the first digestion was lyophilized and 
redissolved in 50 mM potassium phosphate (pH 7.8) and 1 M urea to 
provide endoproteinase Glu-C (Sigma) specificity for cleavage at Asp 
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Fig. 3. HPLC purification profile of active-site peptide. Elution of the labeled peptide following thermolysin digestion was monitored at (A) 
214 nm and (B) 440 nm. Elution following the GIu-C digestion was monitored at (C) 214 nm and (D) 440 nm. 
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and Glu residues [18]. Digestion was initiated by the addition of 2% 
(w/w) GIu-C at 37°C with shaking [18], terminated after 6 h as de- 
scribed above, and separated as before using a linear gradient from 
35-55% solvent B over 40 min. Yield was 42% for the subdigestion 
based on radioactivity inthe peptide peak relative to that injected on 
the HPLC column. 
The resulting peptide was sequenced by automated Edman degra- 
dation. Resonance Raman spectra were obtained using methods and 
instruments a described [19,20]. 
3. Results and discussion 
Purified P. pastoris lysyl oxidase was titrated with phenyl- 
hydrazine hydrochloride to form the corresponding phenylhy- 
drazone with maximal absorbance at448 nm as shown in Fig. 
2. This spectrum is similar to those observed for phenylhy- 
drazone derivatives of other TPQ-containing enzymes (see 
[2,3]). 
[14C]Phenylhydrazine-labeled enzyme was reduced and car- 
boxymethylated [16] and subsequently digested with thermo- 
lysin. The active-site peptide was purified by reverse-phase 
HPLC. Fig. 3A,B shows a representative HPLC elution pro- 
file monitored at 214 and 440 nm. The majority of the chro- 
mophore luted in one peak, was collected, and was quantified 
by measuring the incorporation of radioactivity. To reduce 
the size and increase the purity of the active-site peptide, the 
thermolysin peptide fragment was further digested with endo- 
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Table 1 
Edman sequencing of the peptide from the Glu-C digestion of P. 
pastoris lysyl oxidase 
Cycle number Glu-C peptide AGAO b Lysyl 
oxidase c 
Amino acid Yield (pmol) 
1 Ile 23 Ile Tyr 
2 Gly 44 Gly Asp 
3 Asn 38 Asn Thr 
4 blank ~ TPQ LTQ 
5 Asp 28 Asp Gly 
6 Tyr 15 Tyr Ala 
7 Asn 23 Gly Asp 
~No amino acid was identified at this position. 
bSee [21]. 
proteinase Glu-C. Fig. 3C,D shows a typical elution profile 
for the Glu-C digestion followed at 214 and 440 nm. Again, 
the chromophore luted in one major peak which was col- 
lected and quantified by measuring 14C incorporation. 
The sequence of the active-site peptide was determined by 
standard Edman degradation. For comparison, Table 1 shows 
the active-site sequence of P. pastoris lysyl oxidase is aligned 
with active-site sequences from Arthrobactor globiformis phen- 
ethylamine oxidase (AGAO), a TPQ-containing enzyme [21], 
and LTQ-containing lysyl oxidase [11]. A blank in the amino 
acid sequencing data was seen at the site of the modified 
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Fig. 4. Comparison of the resonance Raman of the P. pastoris lysyl oxidase phenylhydrazone, thederivatized active-site peptide, and the syn- 
thetic topa quinone-hydantoin derivative. (A) phenylhydrazone of the enzyme; (B) peptide phenylhydrazone; (C) phenylhydrazone of topa qui- 
none hydantoin. 
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tyrosine for both AGAO and mammalian lysyl oxidase 
[11,21]. The P. pastoris peptide contains the Asn-BLANK- 
Asp/Glu consensus equence for TPQ and is very similar to 
the AGAO active-site sequence. There is no apparent homol- 
ogy with the mammalian lysyl oxidase active-site sequence. 
Additionally, two amino acid residues would have been de- 
tected in each Edman round if P. pastoris lysyl oxidase con- 
tained a cross-linked cofactor like LTQ. The presence of the 
TPQ consensus sequence [22] strongly suggests the presence of 
this cofactor. 
Resonance Raman spectroscopy has been used as a sensi- 
tive probe for the structure of quinone cofactors [2,3,20,23]. 
Active-site-derived peptides of mammalian lysyl oxidase ex- 
hibit resonance Raman spectra that are readily distinguished 
from TPQ-containing enzymes [11]. Resonance Raman spec- 
tra of the phenylhydrazone d rivatives of P. pastoris lysyl 
oxidase and its active-site peptide are compared to the deriv- 
atized TPQ model compound in Fig. 4; these spectra are 
essentially superimposable. Further, the resonance Raman 
spectrum of the p-nitrophenylhydrazone derivative is also 
nearly identical to that of a corresponding derivative of a 
TPQ model (data not shown). These results provide very 
strong evidence for the presence of TPQ in P. pastoris lysyl 
oxidase. 
The presence of TPQ in the Pichia pastoris lysyl oxidase is 
surprising considering the very similar substrate specificity 
between this amine oxidase and mammalian lysyl oxidase. It 
is clear, therefore, that the quinone cofactor is not involved in 
conferring substrate specificity. A complete amino acid se- 
quence for P. pastoris lysyl oxidase would allow comparison 
to mammalian lysyl oxidase sequences and may reveal homol- 
ogy in those regions involved in substrate recognition. The 
failure thus far to find a non-mammalian LTQ-containing 
enzyme suggests a unique evolution of both structure and 
function among the family of lysyl oxidase nzymes in higher 
organisms. 
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